Enlivex Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $121k | 130k | 0.93 |
| 2024-12-31 | $1.2k | 1.1k | 1.17 |
| 2024-09-30 | $244 | 145 | 1.68 |
| 2023-12-31 | $717 | 266 | 2.70 |
| 2023-09-30 | $1.3k | 838 | 1.58 |
| 2023-06-30 | $2.2k | 838 | 2.63 |
| 2023-03-31 | $3.1k | 838 | 3.64 |
| 2022-12-31 | $2.5k | 647 | 3.94 |
| 2022-06-30 | $4.9k | 1.2k | 4.00 |
| 2021-12-31 | $21k | 3.3k | 6.37 |
| 2021-06-30 | $9.0k | 897 | 10.00 |
| 2021-03-31 | $31k | 3.1k | 10.00 |
| 2020-12-31 | $26k | 3.1k | 8.33 |
| 2019-12-31 | $0 | 28 | 0.00 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation